Immunex Enbrel
Executive Summary
"Dear Doctor" letter for etanercept issued Oct. 10 warns of neurologic and hematologic events seen post-marketing. The letter follows a similar announcement in Europe (1"The Pink Sheet" Oct. 9, p. 16)
"Dear Doctor" letter for etanercept issued Oct. 10 warns of neurologic and hematologic events seen post-marketing. The letter follows a similar announcement in Europe (1 (Also see "Enbrel "Dear Doctor" Letter Possible Following Hematologic Adverse Events" - Pink Sheet, 9 Oct, 2000.)). |